Markets:

Overview

News

Currencies

International

Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

34.56 +1.71 (+5.21%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Structure Therapeutics Inc. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >

7 Small-Cap Stocks that Wall Street Loves for Good Reason ↗

March 30, 2024

As small-cap stocks start to catch up to the market rally, it's time to look at seven small-cap stocks that Wall Street loves.

Via InvestorPlace

GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023 ↗

March 15, 2024

GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

March 08, 2024

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

March 08, 2024

From Structure Therapeutics Inc.

Via GlobeNewswire

2 Biotech Stocks That Could Soar in December ↗

November 26, 2023

These two biotechs have important catalysts coming up in December.

Via The Motley Fool

What 6 Analyst Ratings Have To Say About Structure Therapeutics ↗

November 15, 2023

Via Benzinga

4 Analysts Have This to Say About Structure Therapeutics ↗

October 19, 2023

Via Benzinga

The Best-Performing U.S. IPOs Of 2023 ↗

February 04, 2024

In 2023, there were 154 IPOs on the U.S. stock market. Here is a look at some of the best initial public offerings from last year.

Via Talk Markets

IPO watch 2024: Which new stocks will hit the market?

January 08, 2024

Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies.

Via MarketBeat

Topics Initial Public Offering

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now ↗

December 25, 2023

It has genuine struggles ahead, but it has some actual value in hand as well.

Via The Motley Fool

7 Small-Cap Stocks That Wall Street Loves for Good Reason ↗

December 22, 2023

The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading

Via InvestorPlace

Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review ↗

December 22, 2023

Despite a Wednesday tumble, the major indexes are right at 2023 highs.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 19, 2023

Via Benzinga

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher ↗

December 18, 2023

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07....

Via Benzinga

Topics Stocks

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 18, 2023

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 18, 2023

Via Benzinga

Crude Oil Rises 3%; US Housing Market Index Increases In December ↗

December 18, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Novo Nordisk's Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today? ↗

December 18, 2023

Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development program update for its highly selective oral GLP-1

Via Benzinga

Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel ↗

December 18, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.15% to 37,362.28 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Structure Stock Takes A Brutal Beating After Obesity Drug Trails Lilly's Leader ↗

December 18, 2023

The company is hoping to break into the pack with an oral GLP-1 agonist.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 18, 2023

Via Benzinga

Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study

December 18, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 ↗

December 11, 2023

Some of the most explosive opportunities can be found in biotech stocks. In fact, as we head into New Year 2024, here are three to consider.

Via InvestorPlace

If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names ↗

November 29, 2023

As we head into December 2023, some of the hottest investment opportunities can be found in these biotech stocks.

Via InvestorPlace

Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

November 14, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Should You Still Buy the Nasdaq's Best-Performing October Stocks? ↗

November 03, 2023

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

Via The Motley Fool

Top 5 Health Care Stocks That Should Keep You Up At Night ↗

October 26, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023 ↗

October 19, 2023

Via Benzinga

Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

October 19, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

Via FinancialNewsMedia

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.